Mohamed-Iqbal Ravalia

YOUNG TRAINEES AND STUDENTS: Advocate for continued support of and investment in the next generation of highly skilled researchers through the federal awards system for doctoral students, post-doctoral trainees and fellows. RESEARCH HOSPITALS: Advocate for direct support and stability for Canada's academic health science centres and research hospitals that will further enable them to fulfill their strategically critical contribution to Canada's health and economic security. INDUSTRY: Advocate for policies that enhance the health and biosciences sector’s capacity to do business in Canada and to invest in Canadian health research and commercialization. INDIRECT COSTS OF RESEARCH: Advocate for an increase to the minimum threshold for reimbursement of indirect research costs for all institutions via the Research Support Fund. INDIGENOUS RESEARCH: Advocate for greater investments in Indigenous health research through the three granting councils and the Canada Research Coordinating Committee. HEALTH RESEARCH: Focus on increasing public investments across the research spectrum of operating grants, people and infrastructure and encourages investments from private and private-not-for-profit sectors. GOVERNMENT FUNDING: Advocate for increased health research funding through the three granting councils (Canadian Institutes of Health Research, Social Sciences and Humanities Research Council, and Natural Sciences and Engineering Research Council of Canada) and the Canada Research Coordinating Committee. FEDERAL BUDGET CONSULTATION: Advocate for continued support of Canadian health research and health innovation through investments and commitments made in the federal budget, such as the Strategic Science Fund, the Canada Graduate Scholarship Program, etc. DIVERSE TALENT BASE: Advocate for better support for a diversified talent base in Canada, with a focus on Indigenous researchers, Black and people of colour researchers, early-career researchers, and other underrepresented and equity-deserving groups. DIGITAL HEALTH SYSTEM: Advocate for investment in the digitalization of our health system so that high-quality data and digital technologies support healthcare decisions, empower patients as partners, and drive research and innovation.

Agriculture industry as it relates to growth. Supply management system as it relates to the chicken sector. Environment initiatives as they relate to the chicken industry. Chicken Farmers of Canada’s Raised by a Canadian Farmer Animal Care Program. World Trade Organization agreements (WTO) as they relate to the negotiations on agriculture. The Agreement on Internal Trade (AIT) as it relates to supply management. Regional and Bilateral Trade Negotiations with regard to possible impact on the Canadian chicken sector. Meat Inspection Regulations with respect to poultry processing. Health of Animals Act and Regulations dealing with the development and refinement of animal disease preparedness and response protocols. Funding for the development and implementation of on-farm programs. Tariff classifications, Tariff enforcement, Duties Deferral and Drawback Programs. Consumer Packaging and Labeling Regulations with respect to production claims on labels. Administration and allocation of the Tariff Rate Quota. Canadian Food Inspection Agency programs related to the chicken industry. Canada-United States-Mexico Agreement related to chicken products and the chicken sector. Animal Health Products (antimicrobials, vaccines, feed/water additives) availability in Canada.

Supply management system as it relates to the chicken sector. World Trade Organization agreements (WTO) as they relate to the negotiations on agriculture. The Agreement on Internal Trade (AIT) as it relates to supply management. Tariff classifications, Tariff enforcement, Duties Deferral and Drawback Programs. Regional and Bilateral Trade Negotiations with regard to possible impact on the Canadian chicken sector. Meat Inspection Regulations with respect to poultry processing. Environment initiatives as they relate to the chicken industry. Consumer Packaging and Labeling Regulations with respect to production claims on labels. Chicken Farmers of Canada’s Raised by a Canadian Farmer Animal Care Program. Canadian Food Inspection Agency programs related to the chicken industry. Canada-United States-Mexico Agreement related to chicken products and the chicken sector. Health of Animals Act and Regulations dealing with the development and refinement of animal disease preparedness and response protocols. Funding for the development and implementation of on-farm programs. Administration and allocation of the Tariff Rate Quota. Animal Health Products (antimicrobials, vaccines, feed/water additives) availability in Canada.

Supply management system as it relates to the chicken sector. Environment initiatives as they relate to the chicken industry. Chicken Farmers of Canada’s Raised by a Canadian Farmer Animal Care Program. World Trade Organization agreements (WTO) as they relate to the negotiations on agriculture. The Agreement on Internal Trade (AIT) as it relates to supply management. Regional and Bilateral Trade Negotiations with regard to possible impact on the Canadian chicken sector. Canada-United States-Mexico Agreement related to chicken products and the chicken sector. Meat Inspection Regulations with respect to poultry processing. Health of Animals Act and Regulations dealing with the development and refinement of animal disease preparedness and response protocols. Funding for the development and implementation of on-farm programs. Tariff classifications, Tariff enforcement, Duties Deferral and Drawback Programs. Consumer Packaging and Labeling Regulations with respect to production claims on labels. Administration and allocation of the Tariff Rate Quota. Canadian Food Inspection Agency programs related to the chicken industry. Animal Health Products (antimicrobials, vaccines, feed/water additives) availability in Canada.

Policy and Programs Health Canada and Public Health Agency of Canada policies and programs to prevent and treat HIV and eliminate hepatitis as a public health threat by 2030, as part of Canada's commitments under the Global Viral Hepatitis Strategy and therapeutic efforts against the fight for COVID-19. Patent Act Regulations as they relate to the regulation of intellectual property for therapeutic products, specifically the Patented Medicines (Notice of Compliance) Regulations Patented Medicine Prices Review Board (PMPRB) Regulations with regard to reporting requirements, pricing, guidelines and dispute resolution. Innovation Agenda, particularly with respect to initiatives to support and attract investments in the life sciences sector Federal Government First Nations and Inuit Health Branch program with respect to health services. Federally-funded Public Drug Plans, with respect to reimbursement for drug products for federal plan beneficiaries. Canada Agency for Drugs and Technologies in Health (CADTH) as it relates to health economics assessment and recommendations made on new medicines.

We will be meeting with public office holders to advocate for health solutions within First Nations, Metis, and Inuit communities.

Invitations to a roundtable event to discuss HIV in Canada will be going to several MPs and Senators.

Provide support to inform and enable Canada to meet it's international committments on Fast-Track strategy to end the AIDS epidemic by 2030

Agricultural Trade - support multi-lateral and bi-lateral trade negotiations and policies that provide free and open access to new markets through reduced tariffs and non-tariff barriers on canola and its products. Provide farmers necessary through trade disruptions. support the modernization of the World Trade Organization(WTO) as a mechanism to promote rules based trade. Support additional government resources to help solve technical trade barriers. Transportation - ensure the Canada Transportation Act works in the best possible way for the Agricultural sector International Trade - multi and bi-lateral trade negotiations to maintain and increase canola exports. Support the modernization of the World Trade Organization as a mechanism to promote rules-based trade. Support additional government resources to help solve technical trade barriers. Income Tax Act and other financial regulations, policies or programs: To promote the fair treatment of farmers in any proposed changes to the Income Tax Act or other financial mechanism that may impact farmer financially. Ensure governments recognize the benefits that farmers provide to the environment. Including in relation to polices and regulations concerning carbon pricing, as it pertains to on-farm exemptions, offset protocols, rebates, and research. Economic Development - supporting the economic development of rural communities and the Canadian economy by advocating for policies that help farmers succeed. Climate change laws, policies, programs and regulations related to agriculture, promote competitiveness and production on farms. climate/environment - Renewable Fuels, supporting the development of renewable fuels in Canada. Canada's Clean Fuel standard incentivizes the use of canola bases fuels. Canadian Environmental Protection Act and Pest Control Products Act and regulations as it relates to agricultural pest control products. Support enhanced resources for federal regulatory bodies to make science-based decisions on crop protection products and seed varieties. Advocate for clear, science and risk-based approach to regulation of pesticides and new plant breeding innovation and that it is facilitative for trade. Canada Water Agency - to create and implement and adapt a pan Canadian water monitoring framework that would have positive impacts for canola farmers Canada Grains Act - to support a review of and modernize the role of the Canadian Grain Commission to align with the needs of the grain sector. Agriculture - policies and programs Growing Forward and the impact on the Agriculture Industry

Agricultural Trade - Support multi-lateral and bi-lateral trade negotiations and policies that provide more free and open access to existing and new markets through reduced tariffs and non-tariff trade barriers on canola and its products. Provide farmers necessary support through trade disruptions. Support the modernization of the World Trade Organization (WTO) as a mechanism to promote rules-based trade. Support additional government resources to help solve technical trade barriers. Ensure Government recognizes and works with the agriculture sector to ensure farmers have access to skilled, competitive on-farm labour. Environment and international trade: to advance the good management practices that are implemented on canola farms that contribute to environmental stewardship and competitive markets for farmers and to advance the canola biodiesel market domestically and abroad. Canada's Clean Fuel Regulations incentivizes the use of canola-based biofuels. Support right to repair and interoperability programs, policies, laws, and regulations that support farmer's choice and right to repair. Discussions concerning railway and port strikes as it relates to economic development and trade labour disruptions. Transportation: to advocate for a fair and efficient railway transportation system that serves the needs of grain producers. Canada Transportation Act and regulations as it relates to the transportation of grain. Support development of transportation and trade infrastructure that facilities market demand and growth for canola. Support a review of the Canada Grains Act to modernize role of Canadian Grain Commission to align with needs of the grain sector. Income Tax Act and other financial regulations, policies or programs: To promote the fair treatment of farmers in any proposed changes to the Income Tax Act or other financial mechanism that may impact farmers financially. Ensure governments recognize the benefits that farmers provide to the environment. Including in relation to polices and regulations concerning carbon pricing, as it pertains to on-farm exemptions, offset protocols, rebates, and research. Climate change laws, policies, programs and regulations related to agriculture promote competitiveness and production on farms. Canadian Environmental Protection Act and Pest Control Products Act and regulations as it relates to agricultural pest control products. Support enhanced resources for federal regulatory bodies to make science-based decisions on crop protection products and seed varieties. Advocate for clear, science and risk-based approach to regulation of pesticides and new plant breeding innovation and that it is facilitative for trade. Agriculture - Work to ensure the existing and upcoming Agricultural Policy Framework addresses the needs of canola farmers including business risk management, marketing and research. Maintain support for federal and shared funded programs.

Agricultural trade: multi and bi-lateral trade negotiations to maintain and expand opportunities for canola farmers through reduction in tariffs and non-tariff trade barriers. Provide farmers necessary support through trade disruptions. Support the modernization of the World Trade Organization (WTO) as a mechanism to promote rules-based trade. Support additional government resources to help solve technical trade barriers. Inter-provincial regulations support canola production, market access, and growth. Agriculture Policy Framework: ensure that business risk management programs and strategic initiatives are suitable for canola farmers. Federal research programming and initiatives support production needs on farm. Support right to repair and interoperability programs, policies, laws, and regulations that support farmer's choice and right to repair. Canada Transportation Act and regulations as it relates to the transportation of grain. Support development of transportation and trade infrastructure that facilities market demand and growth for canola. Ensure governments recognize the benefits that farmers provide to the environment, including in relation to offset protocols, ecological goods and services, and rebates. Support on-farm exemptions for carbon pricing. Climate change laws, policies, programs, research, and regulations related to agriculture promote competitiveness and production on farms. Environment and international trade: to advance the good management practices that are implemented on canola farms that contribute to environmental stewardship and competitive markets for farmers and to advance the canola biodiesel market domestically and abroad. Canada's Clean Fuel Regulations incentivizes the use of canola-based biofuels. Transportation: to advocate for a fair and efficient railway transportation system that serves the needs of grain producers. The creation and implementation of the Canada Water Agency and adoption of a pan-Canadian water monitoring framework have positive impacts for canola farmers. Support enhanced resources for federal regulatory bodies to make science-based decisions on crop protection products and seed varieties. Seeds Act and regulations as it pertains to seed variety registrations. Plant Breeders Rights Act and regulations as it relates to intellectual property rights. Patent Act and regulations as it pertains to intellectual property rights specific to seed technologies. Income Tax Act and other financial regulations, policies or programs: To promote the fair treatment of farmers in any proposed changes to the Income Tax Act or other financial mechanism that may impact farmers financially. Fisheries Act regulations and polices as it relates to fish habitats on farmland. Ensure Government recognizes and works with the agriculture sector to ensure farmers have access to skilled, competitive on-farm labour. Discussions concerning railway and port strikes as it relates to economic development and trade labour disruptions. Canadian Food Inspection Act and regulations as it relates to canola production and trade. Canadian Environmental Protection Act and Pest Control Products Act and regulations as it relates to agricultural pest control products. Canada Grain Act and Canada Grain Act Regulations as it relates to grain handling and transportation. Broadband: Expedite and support efforts to bring affordable, reliable high-speed internet and mobile coverage to rural and remote communities. Agricultural Marketing Programs Act and regulations as it pertains to the Advance Payments Program.

BUDGET: Provide CMA’s perspective on the Government of Canada’s budget, particularly as it relates to modernizing Canada’s health care system by enhancing efficiency, driving innovation, and promoting equitable access to care. HARMFUL ONLINE CONTENT: Advocate to address the escalation of online harassment, intimidation, and threats of violence targeting physicians, other health workers, and anyone seeking health care treatment, including measures to strengthen the Criminal Code of Canada and the Canadian Human Rights Act. TECHNOLOGY AND ARTIFICIAL INTELLIGENCE: provide CMA’s perspective on the impact of technology and artificial intelligence on the health care sector and the means through which advancements can be foreseen and managed. HEALTH DATA INTEROPERBILITY: Provide CMA’s perspective as it relates to health data interoperability that would ensure providers have access to the right information at the right time when providing care, and improve patient outcomes and their health care experience. The CMA is advocating that the trade of medical goods and medications be protected to avoid disruptions to patient care. Specifically, that the government: Continue to ensure pharmaceutical products and medical devices are not included in any countermeasures on tariffs. Improve safeguards for Canadian health data. Improve labour mobility so physicians can work across the country. Make it easier for qualified physicians to immigrate and work in Canada, including by fast-tracking immigration steps for US physicians. MEDICAL MIS/DISINFORMATION: Provide CMA’s perspective on the impacts of medical misinformation and disinformation, including on public trust in science, medicine, and public health experts. PAN CANADIAN LICENSURE: Advocate for the ability for physicians with full licences to practise independently without restrictions or for medical resident trainees registered in any Canadian jurisdiction to practise or train in any other Canadian jurisdiction without having to acquire more than one licence or pay additional licensing fees. This includes exploring enabling legislation in the provinces and territories. INTEGRATED HEALTH HUMAN RESOURCES: Advocate for an Integrated Health Human Resources Strategy, including creating retention incentives and addressing administrative burden for health care professionals, increasing the number of doctors and nurses and ensuring that every Canadian has access to a family doctor or primary health team, increasing access to virtual care, creating an action plan to get internationally trained health care professionals to work, improving workforce data collection across health systems and investing in a supply needs-based planning tool, and facilitating team-based health care. ADMINISTRATIVE BURDEN: Advocate for measures to alleviate the administrative burden on physicians and support their professional wellbeing, including investment to facilitate the development of EHRs and EMRs in Canada, improved remuneration for the completion of federal health forms, ensuring that physicians are not captured in the definition of "promoters" in the Disability Tax Credit Promoters Restrictions Regulations, and advocacy on discontinuing the requirement that employees present sick notes to their employers. INDIGENOUS HEALTH: Improvement to the health and health care services provided to Indigenous peoples in Canada, including adding inclusive lettering on health cards across Canada. Advocating for the creation of a national Chief Health Accountability Officer. PUBLIC-PRIVATE HEALTHCARE: The CMA is conducting a series of in-person sessions across the country to engage key stakeholders, including the public, physicians, patients/PWLE, policymakers, system leaders and others, in a dialogue on public-private healthcare. What we hear will inform CMA policy moving forward, and our recommendations for action at a national level. PHYSICIAN PARLIAMENTARIAN CAUCUS: advocate for the formation of a Physician Parliamentarian

HEALTH DATA INTEROPERBILITY: Provide CMA’s perspective as it relates to health data interoperability that would ensure providers have access to the right information at the right time when providing care, and improve patient outcomes and their health care experience. BUDGET: Provide CMA’s perspective on the Government of Canada’s budget, particularly as it relates to modernizing Canada’s health care system by enhancing efficiency, driving innovation, and promoting equitable access to care. HARMFUL ONLINE CONTENT: Advocate to address the escalation of online harassment, intimidation, and threats of violence targeting physicians, other health workers, and anyone seeking health care treatment, including measures to strengthen the Criminal Code of Canada and the Canadian Human Rights Act. TECHNOLOGY AND ARTIFICIAL INTELLIGENCE: provide CMA’s perspective on the impact of technology and artificial intelligence on the health care sector and the means through which advancements can be foreseen and managed. HEALTH PROMOTION AND DISEASE PREVENTION: Increased investments in health and social-determinants-of-health related programs, including measures to address the opioid crisis, mental health and addictions, and the regulation of natural health products. ADMINISTRATIVE BURDEN: Advocate for measures to alleviate the administrative burden on physicians and support their professional wellbeing, including investment to facilitate the development of EHRs and EMRs in Canada, improved remuneration for the completion of federal health forms, the development of a Federal Disability Benefit, ensuring that physicians are not captured in the definition of "promoters" in the Disability Tax Credit Promoters Restrictions Regulations, providing clarity and guidance on federal forms, and advocacy on discontinuing the requirement that employees present sick notes to their employers. The CMA is advocating that the trade of medical goods and medications be protected to avoid disruptions to patient care. Specifically, that the government: Continue to ensure pharmaceutical products and medical devices are not included in any countermeasures on tariffs. Improve safeguards for Canadian health data. Improve labour mobility so physicians can work across the country. Make it easier for qualified physicians to immigrate and work in Canada, including by fast-tracking immigration steps for US physicians. PAN CANADIAN LICENSURE: Advocate for the ability for physicians with full licences to practise independently without restrictions or for medical resident trainees registered in any Canadian jurisdiction to practise or train in any other Canadian jurisdiction without having to acquire more than one licence or pay additional licensing fees. This includes exploring enabling legislation in the provinces and territories. INTEGRATED HEALTH HUMAN RESOURCES Advocate for an Integrated Health Human Resources Strategy, including creating retention incentives and addressing administrative burden for health care professionals, increasing the number of doctors and nurses and ensuring that every Canadian has access to a family doctor or primary health team, increasing access to virtual care, creating an action plan to get internationally trained health care professionals to work, improving workforce data collection across health systems and investing in a supply needs-based planning tool, and facilitating team-based health care. MEDICAL MIS/DISINFORMATION: Provide CMA’s perspective on the impacts of medical misinformation and disinformation, including on public trust in science, medicine, and public health experts. INDIGENOUS HEALTH: Improvement to the health and health care services provided to Indigenous peoples in Canada including adding inclusive lettering on health cards across Canada. Advocating for the creation of a national Chief Health Accountability Officer. PUBLIC-PRIVATE HEALTHCARE: The CMA is conducting a series of in-person sessions across the country to engage key s

TECHNOLOGY AND ARTIFICIAL INTELLIGENCE: provide CMA’s perspective on the impact of technology and artificial intelligence on the health care sector and the means through which advancements can be foreseen and managed. HARMFUL ONLINE CONTENT: Advocate to address the escalation of online harassment, intimidation, and threats of violence targeting physicians, other health workers, and anyone seeking health care treatment, including measures to strengthen the Criminal Code of Canada and the Canadian Human Rights Act. BUDGET: Provide CMA’s perspective on the Government of Canada’s budget, particularly as it relates to modernizing Canada’s health care system by enhancing efficiency, driving innovation, and promoting equitable access to care. HEALTH DATA INTEROPERBILITY: Provide CMA’s perspective as it relates to health data interoperability that would ensure providers have access to the right information at the right time when providing care, and improve patient outcomes and their health care experience. The CMA is advocating that the trade of medical goods and medications be protected to avoid disruptions to patient care. Specifically, that the government: Continue to ensure pharmaceutical products and medical devices are not included in any countermeasures on tariffs Improve safeguards for Canadian health data Improve labour mobility so physicians can work across the country Make it easier for qualified physicians to immigrate and work in Canada, including by fast-tracking immigration steps for US physicians PAN CANADIAN LICENSURE: Advocate for the ability for physicians with full licences to practise independently without restrictions or for medical resident trainees registered in any Canadian jurisdiction to practise or train in any other Canadian jurisdiction without having to acquire more than one licence or pay additional licensing fees. This includes exploring enabling legislation in the provinces and territories. INTEGRATED HEALTH HUMAN RESOURCES: Advocate for an Integrated Health Human Resources Strategy, including creating retention incentives and addressing administrative burden for health care professionals, increasing the number of doctors and nurses and ensuring that every Canadian has access to a family doctor or primary health team, increasing access to virtual care, creating an action plan to get internationally trained health care professionals to work, improving workforce data collection across health systems and investing in a supply needs-based planning tool, and facilitating team-based health care. ADMINISTRATIVE BURDEN: Advocate for measures to alleviate the administrative burden on physicians and support their professional wellbeing, including investment to facilitate the development of EHRs and EMRs in Canada, improved remuneration for the completion of federal health forms, ensuring that physicians are not captured in the definition of "promoters" in the Disability Tax Credit Promoters Restrictions Regulations, and advocacy on discontinuing the requirement that employees present sick notes to their employers. MEDICAL MIS/DISINFORMATION: Provide CMA’s perspective on the impacts of medical misinformation and disinformation, including on public trust in science, medicine, and public health experts. INDIGENOUS HEALTH: Improvement to the health and health care services provided to Indigenous peoples in Canada, including adding inclusive lettering on health cards across Canada. Advocating for the creation of a national Chief Health Accountability Officer. PUBLIC-PRIVATE HEALTHCARE: The CMA is conducting a series of in-person sessions across the country to engage key stakeholders, including the public, physicians, patients/PWLE, policymakers, system leaders and others, in a dialogue on public-private healthcare. What we hear will inform CMA policy moving forward, and our recommendations for action at a national level. PHYSICIAN PARLIAMENTARIAN CAUCUS: advocate for the formation of a Physician Parliamentarian Cauc

Advocating for the passing into law of C-284: An Act to establish a national strategy for eye care Raising awareness and educating government regarding vision impairment and eyecare solutions in Canada and abroad.

Raising awareness and educating government regarding vision impairment and eyecare solutions in Canada and abroad. Advocating for the passing into law of C-284: An Act to establish a national strategy for eye care

Engagement with the Government regarding the Life Science Fund seeking partnership and funding to support completion of Phase I and Phase II clinical research program associated to AMR (antimicrobial resistance) Antimicrobial Resistance (AMR) - Seek funding and support for pilot projects making anti-infective medications available to equity seeking populations, helping to combat AMR. Also discuss any applicable conditions regarding this funding. Programs and policy to support Canadian biomanufacturing and access to medicines and vaccines for Canadians. National Immunization Strategy and policies and programs that impact public access to vaccines and disease prevention in Canada. Patented Medicines Review Board (PMPRB), certified under the Patent Act and whose guidelines seek to ensure a balance between the prices set by manufacturers for patented medicines sold in Canada and the maintenance of an attractive environment for pharmaceutical research and development. Engagement with federal officials regarding the Biomanufacturing & Life Sciences Strategy and policies and programming related to biomanufacturing in Canada Access to medicines - government policies, processes, legislation, and/or regulation with potential impact on access to medicines in Canada. Trade-related matters, including policies and tariffs impacting medicines and vaccines. Policies and programs related to the health of new immigrants to Canada. Policies, programs, and funding related to Canada's Sexually Transmitted and Blood-Borne Infections (STBBI) Action Plan 2024-2030. Engagement with federal officials regarding Health Emergency Readiness Canada. The National Pharmaceutical Strategy (NPS) as agreed by First Ministers in 2004. Advocacy for ways to increase access to medicines and vaccines for Canadian patients. The Common Drug Review (CDR) process for reviewing new drugs and providing listing recommendations to publicly funded drug benefit plans in Canada. Ensuring the access needs of Canadian patients are met by advocating on activities undertaken in the context of the CDR. Science and Technology (S&T) Strategy: Mobilizing Science and Technology to Canada's Advantage. Advocacy for measures which will allow for commercialization in health care to occur and for Canada to remain competitive internationally on Intellectual Property and other fronts. Public Services and Procurement Canada (PSPC) Integrity Framework - Clarifying the process for procurement of vaccines and possibly pharmaceuticals under the evolving procurement framework. Patented Medicines (Notice of Compliance) Regulations which seek to balance the protection of Intellectual Property (IP) and patents with cost containment. Advocacy to ensure that IP rights are respected and internationally competitive in order to promote Research and Development. Legislation, regulations, policies and programs concerning the federal government's response to COVID-19, including pandemic preparedness, pharmaceutical and vaccine supply-chain management, and general administration of justice. Food and Drugs Act and the bill formerly known as Bill C-51: An Act to amend the Food and Drugs Act and to make consequential amendments to other Acts. Specifically, with respect to the renewal of the drug approval process. Advocacy to ensure that Canada's review and approval process is timely, safe, effective, competitive and consistent with other jurisdictions. FedDev Ontario Advanced Manufacturing Fund - advancing manufacturing of innovative pharmaceutical products in southern Ontario Engage with government to strengthen the Priority Review for Drug Submissions process. Engage the Government regarding the need for clear and efficient procurement processes for COVID-19 medical countermeasures, including COVID-19 therapeutics, to ensure access for Canadians. Engagement with the Government regarding the Strategic Innovation Fund Drug Re-importation - Raise awareness regarding the potential risks to drug and vaccine supply fo

Fisheries: The object of the lobbying is to promote the benefits of Grieg Seafood's salmon farming investments in Canada and seek a positive path forward for continued investments, job creation, food security, exports, and economic reconciliation with First Nations.

Fisheries: The object of the lobbying is to promote the benefits of Grieg Seafood's salmon farming investments in Canada and seek a positive path forward for continued investments, job creation, food security, exports, and economic reconciliation with Nation(s).

Universal Pharmacare - We advocate for universal national single payer program for prescription medication that would improve coverage across Canada and result in logistical efficiencies for the system. The importance of family medicine research and the impact it has on family medicine, primary care and the health care system. Want to ensure that family medicine research is acknowledged by federal officials as requiring sufficient supports. Scopes of Practice and collaborative care: support for enhanced intra- and inter-professional collaboration Public Health: support for family physician involvement in not only playing a pivotal role in the delivery of public health but also in planning for public health emergencies. Family physicians and their practices are essential in contributing pandemic response and are fundamental partners in supporting large-scale vaccination rollout in all provinces and territories - both as a source of accurate information and delivery points for vaccines. Patient's Medical Home (PMH): identified by its patients as the place that serves as the home base or central hub for the timely provision and/or coordination of all their health and medical care needs. Implementation of PMH is desired across Canada, including appropriate integration of virtual care and its application as a part of longitudinal relationship-based care in alignment with the PMH vision. Looking for support for and understanding of the role of social determinants of health (SDoH) and how these determinants, such as poverty, impact Canadians. The CFPC continues to call attention to SDoH, the role family physicians play and the expectations we have of federal decision-makers to acknowledge SDoH when crafting policies and programs. Indigenous Health: support for health care initiatives and education that improve health outcomes for Indigenous people of Canada and address the adverse effects of systemic racism, in line with the Truth and Reconciliation Commission of Canada’s calls for action. The CFPC maintains strong support of the proposed National Consortium for Indigenous Medical Education involving medical learners, educators, and physicians to ensure that training and continued professional development in caring for Indigenous patients are delivered through a lens of cultural humility and cultural safety. Health Human Resources: encourage support for the College of Family Physician's goal of every Canadian having their own family physician. The College of Family Physicians of Canada is also recommending increased federal support for a pan-Canadian health human resources plan to strengthen primary care. Investment into Primary Health Care Transition Fund would help improve Canada-wide access to family practices and allied primary care.

Support family doctors with teams, as that is a key enabler to providing high quality primary care. Invest in family medicine by adding new family doctors and directing funding to expand training, have fair compensation, and other recruitment/retention measures. Fund CFPC efforts to streamline foreign credential recognition of internationally educated family physicians to bolster the health workforce. Addressing administrative burden: Administrative burden consistently ranks as a top concern for family physicians. This time comes in the way of providing patient care. One of the significant sources of administrative burden for family physicians is filling out federal health forms.

Connected Care for Canadians Act (BILL S-5) : Urging federal policy makers to adopt this legislation quickly and to ensure that it is supported by a robust set of regulations. Provide CFPC's perspective on Federal Budget 2025's initiative to “Improving Access to Health Care in the Arctic and the North”. Funds should be directed to supporting family practices, as part of the Federal government's Health Infrastructure Fund announced in Budget 2025. Fulfill key investments to support family doctors, promised by the Liberal Party during the 2025 Federal elections. This includes initiatives to provide admin burden relief, set up a new FP practice fund, and create new residency seats. Indigenous Health: support for health care initiatives and education that improve health outcomes for Indigenous people of Canada and address the adverse effects of systemic racism, in line with the Truth and Reconciliation Commission of Canada’s calls for action. Support family doctors with teams, as that is a key enabler to providing high quality primary care Fund CFPC efforts to streamline foreign credential recognition of internationally educated family physicians to bolster the health workforce. Invest in family medicine by adding new family doctors and directing funding to expand training, have fair compensation, and other recruitment/retention measures. Addressing administrative burden: Administrative burden consistently ranks as a top concern for family physicians. This time comes in the way of providing patient care. One of the significant sources of administrative burden for family physicians is filling out federal health forms. Universal Pharmacare - We advocate for universal national single payer program for prescription medication that would improve coverage across Canada and result in logistical efficiencies for the system.

Bill S-201, National Framework on Sickle Cell Disease Act, respecting provisions outlined in Section 2, subsections (a), (b), (e), and (i). Proposals to amend guidelines related to the operationalization of the legislation and regulations governing the Patented Medicine Prices Review Board Innovation, Science and Economic Development Canada Innovation and Skills Strategy and other government policies and programs related to incentivizing research and development activities in Canada. Federal programs and budgetary initiatives related to the Federal-Provincial-Territorial funding arrangements regarding pharmaceuticals. Federally-funded Public Drug Plans, with respect to reimbursement for drug products for federal plan beneficiaries. Engagement on issues related to access to medicines, National Pharmacare, and a National Strategy for Drugs for Rare Diseases. Common Drug Review, as it relates to health technology assessments and drug product reimbursement recommendations.

Adoption of Bill S-201, An Act respecting a national framework on sickle cell disease, to discuss measures and initiatives to improve care and treatment of Canadians affected by sickle cell disease and increase public awareness of the disease. Implementation of Canada's action plan for pain and federal initiatives related to pain management. Implementation of the the Pharmacare Act and the National Strategy for Drugs for Rare Diseases Implementation of the National Strategy for Drugs for Rare Disease, and other policies or programs related to rare diseases Regulatory amendments and/or guidelines related to the Food and Drugs Act Regulations and Health Canada to implement an orphan drug regulatory framework. Innovation, Science and Economic Development Canada and Innovation Agenda, Science and Technology Strategy, or other Government policy or program initiatives to support research and development activities and attract investments in Canada, including the Biomanufacturing and Life Sciences Strategy Regulations, guidelines, policies and programs related to regulatory and reporting functions of the Patented Medicine Prices Review Board Enhancement to Canada's regulatory and funding environment for new medicines, including Health Canada authorizations of medicines and framework for clinical trials, health technology assessment processes, reimbursement negotiations and funding decisions. Federally-funded Public Drug Plans, with respect to reimbursement for drug products for federal plan beneficiaries.